V001-9703 Screening compound: 3-(2H-1,3-benzodioxol-5-yl)-N-(diphenylmethyl)-3-{8-methylimidazo[1,2-a]pyridin-3-yl}propanamide

V001-9703 Screening compound: 3-(2H-1,3-benzodioxol-5-yl)-N-(diphenylmethyl)-3-{8-methylimidazo[1,2-a]pyridin-3-yl}propanamide
V001-9703 Screening compound: 3-(2H-1,3-benzodioxol-5-yl)-N-(diphenylmethyl)-3-{8-methylimidazo[1,2-a]pyridin-3-yl}propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V001-9703
3-(2H-1,3-benzodioxol-5-yl)-N-(diphenylmethyl)-3-{8-methylimidazo[1,2-a]pyridin-3-yl}propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V001-9703

Molecular Formula

C31H27N3O3 (C31 H27 N3 O3)

Compound Name

3-(2H-1,3-benzodioxol-5-yl)-N-(diphenylmethyl)-3-{8-methylimidazo[1,2-a]pyridin-3-yl}propanamide

IUPAC name

3-(2H-13-benzodioxol-5-yl)-N-(diphenylmethyl)-3-{8-methylimidazo[12-a]pyridin-3-yl}propanamide

SMILES

Cc1cccn2c1ncc2C(CC(NC(c1ccccc1)c1ccccc1)=O)c(cc1)cc2c1OCO2

InChI

InChI=1S/C31H27N3O3/c1-21-9-8-16-34-26(19-32-31(21)34)25(24-14-15-27-28(17-24)37-20-36-27)18-29(35)33-30(22-10-4-2-5-11-22)23-12-6-3-7-13-23/h2-17,19,25,30H,18,20H2,1H3,(H,33,35)/t25-/m1/s1

InChI Key

WFMIWEGEKBBFNP-RUZDIDTESA-N

MDL Number (MFCD)

MFCD19775840

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

489.57

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.546

Distribution Coefficient, logD

5.524

Water Solubility, LogSw

-5.28

Polar Surface Area

49.042

Acid Dissociation Constant (pKa)

10.00

Base Dissociation Constant (pKb)

6.09

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

16.10

V001-9703 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with V001-9703 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V001-9703?
Check Price and Availability of V001-9703, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V001-9703 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V001-9703
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V001-9703
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V001-9703 available by request